Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yasumichi Takada"'
Autor:
Akihiro Koga, Toshiyuki Matsui, Noritaka Takatsu, Yasumichi Takada, Masahiro Kishi, Yutaka Yano, Takahiro Beppu, Yoichiro Ono, Kazeo Ninomiya, Fumihito Hirai, Takashi Nagahama, Takashi Hisabe, Yasuhiro Takaki, Kenshi Yao, Hirotsugu Imaeda, Akira Andoh
Publikováno v:
Intestinal Research, Vol 16, Iss 2, Pp 223-232 (2018)
Background/AimsDecreased trough levels of infliximab (TLI) and antibodies to infliximab (ATI) are associated with loss of response (LOR) in Crohn's disease. Two prospective studies were conducted to determine whether TLI or ATI better correlates with
Externí odkaz:
https://doaj.org/article/b4f642de10754961b41fd5f4fe788d0a
Autor:
Masahiro Kishi, Fumihito Hirai, Noritaka Takatsu, Takashi Hisabe, Yasumichi Takada, Tsuyoshi Beppu, Ken Takeuchi, Makoto Naganuma, Kazuo Ohtsuka, Kenji Watanabe, Takayuki Matsumoto, Motohiro Esaki, Kazutaka Koganei, Akira Sugita, Keisuke Hata, Kitarou Futami, Yoichi Ajioka, Hiroshi Tanabe, Akinori Iwashita, Hirotaka Shimizu, Katsuhiro Arai, Yasuo Suzuki, Tadakazu Hisamatsu
Publikováno v:
Journal of Gastroenterology. 57:246-266
Many clinical trials have been conducted for inflammatory bowel disease (IBD), so various clinical indices (CIs) and endoscopic indices (EIs) have also been evaluated. However, recently, with the progress of IBD management, review of established indi
Autor:
Masaki Miyaoka, Kenshi Yao, Teruyuki Takeda, Tsuyoshi Beppu, Fumihito Hirai, Toshiharu Ueki, Noritaka Takatsu, Hisatomi Arima, Yasumichi Takada, Masahiro Kishi, Takashi Hisabe
Publikováno v:
Digestive Endoscopy. 34:517-525
BACKGROUND AND AIMS Efficacy of endoscopic balloon dilation (EBD) for intestinal strictures in patients with Crohn's disease (CD) receiving anti-tumor necrosis factor alpha antibodies (anti-TNF) as maintenance therapy is unclear. We investigated the
Autor:
Tsuyoshi Beppu, Masaki Miyaoka, Tosiharu Ueki, Kenshi Yao, Takashi Hisabe, Teruyuki Takeda, Noritaka Takatsu, Yasumichi Takada, Masahiro Kishi, Fumihito Hirai
Publikováno v:
Journal of Gastroenterology
Enteral nutrition (EN) is effective in Crohn’s disease (CD) patients and has been shown to have an inhibitory effect on loss of response to anti-tumor necrosis factor (TNF)-alpha antibody therapy; however, the current level of evidence is not suffi
Autor:
Shigeyoshi Yasukawa, Masakazu Washio, Masahiro Kishi, Fumihito Hirai, Takashi Hisabe, Toshiyuki Matsui, Hiroshi Tanabe, Yuho Sato, Kitaro Futami, Yasumichi Takada, Yutaka Yano, Toshiharu Ueki, Tsuneyoshi Yao, Suketo Sou, Akinori Iwashita, Kenshi Yao, Daijiro Higashi, Yoichiro Ono, Noritaka Takatsu, Takashi Nagahama, Toshihiro Sakurai
Publikováno v:
Journal of Gastroenterology. 56:1111-1112
Autor:
Toshiyuki Matsui, Yuki Okado, Kenshi Yao, Noritaka Takatsu, Yasumichi Takada, Yuho Sato, Takashi Hisabe, Toshiharu Ueki, Masahiro Kishi, Rino Yamaoka, Kazeo Ninomiya, Fumihito Hirai
Publikováno v:
Digestion. 98:119-126
Background: Capsule endoscopy (CE) has allowed the characterization of small bowel lesions. However, small bowel lesions in ulcerative colitis (UC) have not been elucidated and no studies have compared between UC and Crohn’s disease (CD). Aim: The
Autor:
Kitaro Futami, Toshiyuki Matsui, Shigeyoshi Yasukawa, Akinori Iwashita, Masakazu Washio, Masahiro Kishi, Yoichiro Ono, Yuho Sato, Daijiro Higashi, Tsuneyoshi Yao, Takashi Hisabe, Yutaka Yano, Kenshi Yao, Fumihito Hirai, Noritaka Takatsu, Takashi Nagahama, Hiroshi Tanabe, Toshihiro Sakurai, Toshiharu Ueki, Suketo Sou, Yasumichi Takada
Publikováno v:
J Gastroenterol
Journal of Gastroenterology
Journal of Gastroenterology
Background In this study, survival and cause of death were investigated in patients with Crohn’s disease (CD) at a tertiary referral center. Methods A database was created based on the medical records of 1108 CD patients who had a history of visiti
Autor:
Teruyuki Takeda, Yasumichi Takada, Toshiyuki Matsui, Fumihito Hirai, Noritaka Takatsu, Y Yutaka, Masahiro Kishi, Kenshi Yao, Toshiharu Ueki
Publikováno v:
Journal of Crohn's and Colitis. 12:S425-S426
Autor:
Teruyuki Takeda, Toshiyuki Matsui, Fumihito Hirai, Yasumichi Takada, Tsuyoshi Beppu, Kenshi Yao, Toshiharu Ueki, S Ishikawa, Y Yano, K Masahiro
Publikováno v:
Journal of Crohn's and Colitis. 12:S502-S503
Autor:
Toshiyuki Matsui, Kenshi Yao, and Akira Andoh, Takashi Nagahama, Yasuhiro Takaki, Takashi Hisabe, Yasumichi Takada, Masahiro Kishi, Yutaka Yano, Hirotsugu Imaeda, Yoichiro Ono, Takahiro Beppu, Akihiro Koga, Kazeo Ninomiya, Noritaka Takatsu, Fumihito Hirai
Publikováno v:
Intestinal Research, Vol 16, Iss 2, Pp 223-232 (2018)
Intestinal Research
Intestinal Research
Background/Aims: Decreased trough levels of infliximab (TLI) and antibodies to infliximab (ATI) are associated with loss of response (LOR) in Crohn’s disease. Two prospective studies were conducted to determine whether TLI or ATI better correlates